164 related articles for article (PubMed ID: 21720062)
1. Criteria for early identification of aceruloplasminemia.
Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
[TBL] [Abstract][Full Text] [Related]
2. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
4. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
[TBL] [Abstract][Full Text] [Related]
5. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
6. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
[TBL] [Abstract][Full Text] [Related]
7. Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia.
Watanabe M; Asai C; Ishikawa K; Kiyota A; Terada T; Kono S; Miyajima H; Okumura A
Intern Med; 2010; 49(15):1581-5. PubMed ID: 20686294
[TBL] [Abstract][Full Text] [Related]
8. Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.
Kim HK; Ki CS; Kim YJ; Lee MS
Clin Neuroradiol; 2017 Sep; 27(3):385-388. PubMed ID: 28258281
[No Abstract] [Full Text] [Related]
9. Aceruloplasminemia: An entity to consider in patients with anemia.
Lozano-Varela M; Carrera-Alonso E; Plaza-Palacios G
Rev Esp Enferm Dig; 2014 May; 106(5):360-1. PubMed ID: 25287242
[No Abstract] [Full Text] [Related]
10. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
[No Abstract] [Full Text] [Related]
11. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
12. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.
Kang HG; Kim M; Lee SC
JAMA Ophthalmol; 2016 Jul; 134(7):e160816. PubMed ID: 27416276
[No Abstract] [Full Text] [Related]
13. Superficial siderosis associated with aceruloplasminemia. Case report.
Matsushima A; Yoshida T; Yoshida K; Ohara S; Toyoshima Y; Kakita A; Ikeda S
J Neurol Sci; 2014 Apr; 339(1-2):231-4. PubMed ID: 24607334
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing aceruloplasminemia: navigating through red herrings.
Kharel Z; Kharel H; Phatak PD
Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332
[TBL] [Abstract][Full Text] [Related]
15. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene.
Hatanaka Y; Okano T; Oda K; Yamamoto K; Yoshida K
Intern Med; 2003 Jul; 42(7):599-604. PubMed ID: 12879954
[TBL] [Abstract][Full Text] [Related]
16. Molecular and pathological basis of aceruloplasminemia.
Kono S; Miyajima H
Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
[TBL] [Abstract][Full Text] [Related]
18. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.
Kassubek R; Uttner I; Schönfeldt-Lecuona C; Kassubek J; Connemann BJ
J Neurol Sci; 2017 May; 376():151-152. PubMed ID: 28431603
[No Abstract] [Full Text] [Related]
19. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
Parks NE; Vandorpe RA; Moeller JJ
Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
[TBL] [Abstract][Full Text] [Related]
20. Aceruloplasminemia.
Kono S
Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
